ストックスクリーナーアプリを入手
135.98
1.45%
1.94
Teleflex Incorporated (TFX) 最新ニュース
Teleflex (NYSE:TFX) Stock Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive, Globus, Teleflex named top picks at BMO (ISRG:NASDAQ) - Seeking Alpha
Teleflex stock holds steady on its medical device base - AD HOC NEWS
Teleflex Inc : BMO Initiates Coverage With Ou - Moomoo
Teleflex Inc. focuses on medical devices as investors track its Nasdaq listing - AD HOC NEWS
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Teleflex Inc. focuses on medical devices and long-term growth - AD HOC NEWS
Teleflex Publishes 2025 Global Impact Report - Business Wire
Teleflex (TFX) Starts BIOMAG III As Freesolve Progress Tests Its Fair Value Story - Sahm
Teleflex Inc focuses on medical devices as investors watch long term growth - AD HOC NEWS
Teleflex Arrow EZ-IO System from Teleflex Inc.Vascular access tool that is shaping emergency care - AD HOC NEWS
Teleflex Inc. focuses on medical device growth as investors watch US market exposure - AD HOC NEWS
Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Teleflex Inc. focuses on specialty medical devices amid steady demand - AD HOC NEWS
The Teleflex Arrow EZ-IO System. A rugged emergency access tool built for seconds - AD HOC NEWS
Teleflex Q1 2026 slides: earnings beat amid margin pressure, buyback starts early - Investing.com
Teleflex stock leans on its medical devices base - AD HOC NEWS
TFX News | TELEFLEX INC (NYSE:TFX) - ChartMill
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Teleflex Dodges Bid to Revive Patent Case Over Laryngoscopes - Bloomberg Law News
Teleflex Inc. focuses on medical devices as investors watch long-term growth prospects - AD HOC NEWS
Teleflex advances heart scaffold trial, shares trade below recent highs - AD HOC NEWS
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Analysis: A Closer Look At Its 12.34% Potential Upside - DirectorsTalk Interviews
Teleflex Incorporated (TFX) Stock Price Today - CoinMarketCap
The UroLift System from Teleflex Inc.minimally invasive relief for BPH patients - AD HOC NEWS
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex (TFX) Investors? - simplywall.st
Teleflex focuses on vascular devices, peers show sector momentum - Ad-hoc-news.de
Enterprise value to EBITDA forward of Teleflex Incorporated – NYSE:TFX - TradingView
Enterprise value to EBITDA forward of Teleflex Incorporated – BX:TBH - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Inco - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporat - The National Law Review
Price to sales forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Could Be 43% Undervalued Following BIOMAG III Study Enrollment - Sahm
Price to sales forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh - TradingView
Enterprise value to EBIT forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Institutional Ownership 2026 $TFX - MarketBeat
Price to earnings forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex Incorporated Actuals & Estimates (NYSE:TFX) - TradingView
Enterprise value to revenue forward of Teleflex Incorporated – NYSE:TFX - TradingView
TFX Forecast — Price Target — Prediction for 2027 - TradingView
Teleflex launches BIOMAG III trial, analyst consensus on the shares stays cautious - Ad-hoc-news.de
Enterprise value to revenue forward of Teleflex Incorporated – BX:TBH - TradingView
Do Options Traders Know Something About Teleflex Stock We Don't? - TradingView
The Freesolve Resorbable Magnesium Scaffold from Teleflex Inc.global BIOMAG-III trial puts the co - Ad-hoc-news.de
Teleflex Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Teleflex begins enrollment in pivotal resorbable scaffold study By Investing.com - Investing.com Australia
Teleflex begins enrollment in pivotal resorbable scaffold study - Investing.com UK
Teleflex begins enrollment in BIOMAG-III pivotal study - grafa.com
Teleflex Starts Enrollment in Resorbable Magnesium Scaffold Study - Medical Product Outsourcing
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold - Business Wire
Teleflex reports muted share move, analyst metrics frame the stock - AD HOC NEWS
Teleflex Inc (TFX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teleflex Inc (TFX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Teleflex Inc (TFX) Shares Fall 4.2% -- What GF Score of 76 Tells Investors - GuruFocus
Teleflex adjusts debt profile with new senior notes, shares in focus on NYSE - AD HOC NEWS
Teleflex Inc (TFX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Irenic Capital Management LP's Teleflex Inc(TFX) Holding History - GuruFocus
Teleflex StockLong-term strategy and medical device focus - AD HOC NEWS
0.51%
0.12%
大文字化:
|
ボリューム (24 時間):